VANCOUVER, BRITISH COLUMBIA / TheNewswire / August 23, 2017 – Exro Technologies Inc. (formerly BioDE Ventures Ltd.) (the “Company”) announces the grant of 3,725,000 share purchase options to the directors, officers, employees and consultants of the Company.

All share options are exercisable at $0.20 per share in accordance with the terms and conditions of the share option plan of the Company. The total number of directors, officers, employees and consultants of the Company who received options pursuant to this grant is 26.

2,679,000 of the options are vested immediately.  

75,000 of the options are subject to the following vesting schedule: Options will vest in the following portions after the respective periods of time from the grant date: 1/2 immediately, 1/6 after 12 months, 1/6 after 24 months and 1/6 after 36 months.

971,000 of the options are subject to the following vesting schedule: 1/3 after three months, 2/9 after 12 months, 2/9 after 24 months and 2/9 after 36 months.

The Company’s stock option plan was approved by the shareholders at the annual general and special meeting of the Company on December 17, 2015. The number of the common shares which may be issued pursuant to options granted under the plan is 10% of the Issuer’s issued and outstanding shares of the Company.  As of the date of this news release, total outstanding options issued is 3,725,000 and the maximum number of stock options that can be granted by the Company is 4,309,084.

ON BEHALF OF THE BOARD OF DIRECTORS

Mark Godsy

Chief Executive Officer

BioDE Ventures Ltd.

2820 – 200 Granville Street

Vancouver, B.C.  V6C 1S4

Tel: (604) 722-9140